Drug-resistant diarrheogenic Escherichia coli, Mexico

Emerging Infectious Diseases

Volumn 11, Issue 8, 2005, Pages 1306-1308

  Estrada García, Teresa ^a   Cerna, Jorge F ^a,b   Paheco Gil, Leova ^c,d   Velázquez, Raúl F ^b   Ochoa, Theresa J ^e   Torres, Javier ^b   DuPont, Herbert L ^e,f,g  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD JUÁREZ AUTÓNOMA DE TABASCO   (Mexico)

^d Hospital Regional de Alta Especialidad Del Niño Dr Rodolfo Nieto Padrón   (Mexico)

^e UNIVERSITY OF TEXAS   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHILD; DEVELOPING COUNTRY; DIARRHEA; DRUG RESISTANCE; ESCHERICHIA COLI; FEMALE; GENETIC ANALYSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIDRUG RESISTANCE;

EID: 22944483770     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1108.050192     Document Type: Article

References (14)

1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11:142-201.
2. Cohen MB, Nataro JP, Bernstein DI, Hawkins J, Roberts N, Staat MA. Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr. 2005;146:54-61.
3. Lopez-Saucedo C, Cerna JF, Villegas-Sepulveda N, Thompson R, Velazquez FR, Torres J, et al. Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli. Emerg Infect Dis. 2003;9:127-31.
4. Cerna JF, Nataro JP, Estrada-García T. Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol. 2003;41:2138-40.
5. NCCLS. Performance standards for antimicrobial susceptibility testing. Wayne (PA): The Committee; 2002.
6. Todd EC. Epidemiology of foodborne diseases: a worldwide review. World Health Stat Q. 1997;50:30-50.
7. Fegundes-Neto U, Scaletski IC. The gut at war: the consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21-9.
8. Steiner TS, Lima AA, Nataro JP, Guettant RL. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis. 1998;177:88-96.
9. Trabulsi LR, Keller R, Tardelli, Gomes TA. Typical and atypical enteropathogenic Eschericia coli. Emerg Infect Dis. 2002;8:508-13.
10. Afset JE, Bevanger L, Romundstand P, Bergh K. Association of atypical enteropathogenic Escherichia coli (EPEC) with prolonged diarrhea. J Med Microbiol. 2004;53:1137-44.
11. Oberhalm RA, Javier de la Cabada F, Vazquez Garibay E, Bitsura JA, DuPont HL. Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population. J Pediatr. 1987;110:960-5.
12. Putnam SD, Riddle MS, Wierzba TF, Pittner BT, Elyazeed RA, El-Gendy A, et al. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clin Microbiol Infect. 2004;10:804-10.
13. Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial resistant shigellosis in Oregon. Clin Infect Dis. 2000;30:515-9.
14. Bhattacharya SK, Sur D. An evaluation of current shigellosis treatment. Expert Opin Pharmacother. 2003;4:1315-20.